pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
651
stories
5h
Opinion: How Congress can fix expert advisory committees
stat
19h
Dren Bio lands $350M to push rare blood cancer therapy toward market
biospace
21h
Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations
biospace
22h
Chutes & Ladders—Lilly unifies global markets as 36-year vet Patrik Jonsson retires
fiercebiotech
1d
LENZ cuts 75% of staff as third quarter earnings disappoint
biospace
1d
Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure
biospace
1d
Merck outlines 2027 as ‘another year of investment’ despite recent clinical wins
fiercebiotech
1d
Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry
stat
1d
STAT+: Biopharma industry at odds over impact of Treasury’s new China rule
stat
1d
Biopharma cuts at manufacturing plants expected to affect 4,000+
biospace
1d
Early Alert: Medline Removes or Corrects All Medline Brand Beds and Accessories
fda medwatch
1d
Geron’s Rytelo stumbles in phase 3 as Novartis gears up for post-JAK inhibitor blood cancer bid
fiercebiotech
1d
STAT+: Senate candidate El-Sayed wants to ‘grill’ RFK Jr., calls him the ‘most incompetent HHS secretary ever’
stat
1d
GSK vaccine sales miss expectations amid falling demand from adults
biospace
2d
STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
stat
2d
5 new drug launches that defied industry expectations
biospace
2d
Court rejects Novo bid to block Lilly obesity drug ads
biopharma dive
2d
EMSO 2026: Incyte a ‘firm contender’ in G12D pancreatic cancer race as early candidate shines
biospace
3d
Opinion: Cancer vaccines are finally here. How do we get them to patients?
stat
3d
Early Alert: B. Braun Removes Streamline Bloodline Set for Dialog+
fda medwatch
3d
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
stat
3d
US biotechs take lion’s share of $54.5B VC money raised since 2025
biospace
3d
WuXi AppTec raises revenue forecast again in the face of DOD court case
endpoints
3d
#ESMO26: SystImmune/BMS and Hengrui detail data in EGFR-mutant lung cancer
endpoints
4d
The 4 stages of women’s heart health: New framework for doctors and patients
stat
4d
BioNTech sees ‘limited’ benefit to ADC after phase 3 reveals modest efficacy, ILD cases
fiercebiotech
4d
Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapy
biospace
5d
ESMO: J&J exec says RIPTAC readout is ‘best data we’ve ever seen’ for a prostate cancer drug
fiercebiotech
6d
STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclear
stat
6d
STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector
stat
← prev
page 1 of 22
next →
